Castle Biosciences Inc (CSTL)
23.72
+0.82
(+3.58%)
USD |
NASDAQ |
May 03, 10:47
Castle Biosciences Research and Development Expense (Quarterly): 12.99M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.99M |
| September 30, 2023 | 12.92M |
| June 30, 2023 | 13.31M |
| March 31, 2023 | 14.39M |
| December 31, 2022 | 11.31M |
| September 30, 2022 | 10.91M |
| June 30, 2022 | 11.93M |
| March 31, 2022 | 10.76M |
| December 31, 2021 | 9.445M |
| September 30, 2021 | 7.50M |
| June 30, 2021 | 6.793M |
| March 31, 2021 | 5.908M |
| Date | Value |
|---|---|
| December 31, 2020 | 4.581M |
| September 30, 2020 | 3.058M |
| June 30, 2020 | 2.704M |
| March 31, 2020 | 2.913M |
| December 31, 2019 | 3.159M |
| September 30, 2019 | 1.515M |
| June 30, 2019 | 1.317M |
| March 31, 2019 | 1.394M |
| December 31, 2018 | 1.138M |
| September 30, 2018 | 1.294M |
| June 30, 2018 | 1.159M |
| March 31, 2018 | 1.263M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.317M
Minimum
Jun 2019
14.39M
Maximum
Mar 2023
7.759M
Average
7.50M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Exact Sciences Corp | 114.92M |
| Illumina Inc | 341.00M |
| Mettler-Toledo International Inc | 46.44M |
| Waters Corp | 44.39M |
| Natera Inc | 82.96M |